News
Q1 2025 Management View Joe Payne, President and CEO, highlighted heightened interest in the company's mRNA therapeutics pipeline, pointing to forthcoming clinical data for both the ARCT-032 cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback